Anti-Inflammatory and Cytoprotective Actions Inflammation is the bodys defense mechanism, but prolonged inflammation delays recovery and causes further tissue breakdown
Slu-pp-332 (5mg) Buy 1 Buy 2 Save 5% Buy 3 Save 10% Buy 4 Save 15% FOR LABORATORY USE ONLY This product is intended strictly for controlled research environments and must not be: Used in any human or clinical testing Administered to individuals under any circumstances Distributed for unauthorised investigational use Technical Specifications: Synonyms: SLU-PP-332 Chemical Formula: CHClNO CAS Number: Not assigned Molecular Weight: Approx
(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement
B12 (hydroxocobalamin) is a prescription-only medicine in the UK and is safest given by, or under the supervision of, a trained clinician
Duan Y, Li F, Li Y, Tang Y, Kong X, Feng Z, Anthony TG, Watford M, Hou Y, Wu G, Yin Y
Every patient is screened before any peptide is prescribed
